Form 4 for CBT CABOT CORP
Accepted 2021-11-16 00:00:00 ET · period of report 2021-11-12 · accession 0001209191-21-064820 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-16 | 2021-11-12 | CBT | Keohane Sean D | Pres, CEO, Dir | A - Grant | $0.00 | +24.5K | 217.3K | +13% | $0 |
| D | 2021-11-16 | 2021-11-12 | CBT | Keohane Sean D | Pres, CEO, Dir | A - Grant | $0.00 | +104.2K | 104.2K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-12 | A | A | 24,455 | $0.00 | 217,331 | D | — | — | |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2021-11-12 | A | A | 104,231 | $0.00 | 104,231 | D | $58.27 · — to 2031-11-11 | 104,231 Common Stock | (F1) The option vests over a three year period as follows: 30% on November 12, 2022, 30% on November 12, 2023 and 40% on November 12, 2024. |